Please login to the form below
quarterly results
This page shows the latest quarterly results news and features for those working in and with pharma, biotech and healthcare.
Bristol-Myers Squibb’s revenues rise on Celgene acquisition
The positive quarterly results build on BMS’ key patent challenge victory on Wednesday for its blood thinner Eliquis (apixaban). ... One concerning caveat among the otherwise positive results was the decrease in sales for BMS’ immunotherapy Opdivo,
Latest news
-
Solid Q1 results lift Pfizer as it waits for pipeline boost
Shares rose almost 2% in the wake of the presentation. Albert Bourla’s first quarterly results call as chief executive of Pfizer didn’t reveal any big surprises, but it demonstrated ... Albert Bourla, CEO, Pfizer. Much like Eli Lilly, Pfizer’s
-
Keeping it in the family pays dividends
Their approach is very different from big pharma as they aren't distracted by quarterly earnings calls and full year results which allows them to place quite big bets that may
-
GSK's Witty ends on a high, but warns 2017 looking 'uncertain'
Sir Andrew Witty's last results presentation as chief executive of GlaxoSmithKline was a good one, with the UK drugmaker beating analysts' expectations thanks to a good performance for HIV and
-
2017 set to be a "defining year" for AZ
Potential immuno-oncology blockbuster durvalumab leads the charge for AZ’s new launches
-
Tecentriq growth offsets Avastin's US decline at Roche
Shifts focus to newer therapies in anticipation of brewing biosimilar competition
More from news
Approximately 16 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
Interview: Georg Toufar, Mundipharma
This is in contrast to larger public companies that need to answer to shareholders and consistently post positive quarterly results.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- Europe’s cancer community publishes new report on transforming patient care
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AbbVie trial backs chemo-free Imbruvica combo regimen
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- EU to revise pharmaceuticals law amid antibiotic shortages
PMHub
Fishawack Health
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
